Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain.

High resolution 1H NMR spectroscopy was used to analyze temporal lobe biopsies obtained from patients with epilepsy. Heat-stabilized cerebrum, dialyzed cytosolic macromolecules, and perchloric acid extracts were studied using one- and two-dimensional spectroscopy. Anterior temporal lobe neocortex was enriched in GABA, glutamate, alanine, N-acetylaspartate, and creatine. Subjacent white matter was enriched in aspartate, glutamine, and inositol. The N-acetylaspartate/creatine mole ratio was lower in anterior temporal neocortex with mesial (0.66) than neocortical (0.80) temporal lobe epilepsy. Human brain biopsy samples were separated into crude and refined synaptosomes, neuronal cell bodies, and glia using density gradient centrifugation. Neuronal fractions were enriched in glutamate and N-acetylaspartate. Glial cell fractions were enriched in lactate, glutamine, and inositol. The creatine content was the same in biopsied epileptic cortex (8.8-8.9 mmol/kg) and normal in vivo occipital lobe (8.9 mmol/kg). Glutamate content was higher in epileptic cortex at biopsy (10.1-10.5 mmol/kg) than normal in vivo occipital lobe (8.8 mmol/kg). GABA content was higher in biopsies of epileptic cortex (2.3-2.2 mmol/kg) than in normal in vivo occipital lobe (1.2 mmol/kg). N-acetylaspartate content was lower in biopsied epileptic temporal cortex (5.8-6.8 mmol/kg) than normal in vivo occipital lobe (8.9 mmol/kg). Paired in vivo and ex vivo measurements are critical for a firm understanding of the changes seen in the 1H-spectra from patients with epilepsy.

[1]  G Helms,et al.  Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism , 1994, Pediatric Research.

[2]  G B Matson,et al.  Lateralization of human focal epilepsy by 31P magnetic resonance spectroscopic imaging , 1992, Neurology.

[3]  D. Arnold,et al.  Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images , 1994, Annals of neurology.

[4]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[5]  D. Gadian,et al.  Functional magnetic resonance imaging of focal seizures , 1994, Neurology.

[6]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  P. Garcia,et al.  Phosphorus magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy , 1994, Annals of neurology.

[8]  J. Neale,et al.  Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  S R Williams,et al.  Quantitative analysis of 1H NMR detected proteins in the rat cerebral cortex in vivo and in vitro , 1993, NMR in biomedicine.

[10]  R. Connett,et al.  Analysis of metabolic control: new insights using scaled creatine kinase model. , 1988, The American journal of physiology.

[11]  J. Alger,et al.  High‐Resolution Proton Magnetic Resonance Spectroscopy of Rabbit Brain: Regional Metabolite Levels and Postmortem Changes , 1988, Journal of neurochemistry.

[12]  P M Matthews,et al.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.

[13]  B. A. Eagles,et al.  THE CREATINE CONTENT OF BRAIN , 1924 .

[14]  A. Defalco,et al.  THE SYNTHESIS OF CREATINE BY THE BRAIN OF THE INTACT RAT * , 1961, Journal of neurochemistry.

[15]  O. Petroff,et al.  Quantitative analysis of rat synaptosomes and cerebrum using high-resolution 1H magnetic resonance spectroscopy. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[16]  R. Kauppinen,et al.  Brain metabolites as 1H NMR markers of neuronal and glial disorders , 1989, NMR in biomedicine.

[17]  Abel Lajtha,et al.  Handbook of Neurochemistry , 2013, Springer US.

[18]  O. H. Lowry,et al.  DIVERSITY OF METABOLIC PATTERNS IN HUMAN BRAIN TUMORS—I. HIGH ENERGY PHOSPHATE COMPOUNDS AND BASIC COMPOSITION 1 , 1977, Journal of neurochemistry.

[19]  D. Sappey-Marinier High‐resolution NMR spectroscopy of cerebral white matter in multiple sclerosis , 1990, Magnetic Resonance in Medicine.

[20]  M. Farooq,et al.  A MODIFIED PROCEDURE FOR ISOLATION OF ASTROCYTE‐ AND NEURON‐ENRICHED FRACTIONS FROM RAT BRAIN , 1978, Journal of neurochemistry.

[21]  R. Shulman,et al.  Proton NMR Observation of Phenylalanine and an Aromatic Metabolite in the Rabbit Brain in Vivo , 1990, Pediatric Research.

[22]  V. P. Whittaker,et al.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. , 1962, Journal of anatomy.

[23]  O. Petroff,et al.  Metabolic assessment of a neuron‐enriched fraction of rat cerebrum using high‐resolution 1H and 13C NMR spectroscopy , 1993, Magnetic resonance in medicine.

[24]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[25]  J. Urenjak,et al.  Extracellular N‐Acetylaspartate in the Rat Brain: In Vivo Determination of Basal Levels and Changes Evoked by High K+ , 1994, Journal of neurochemistry.

[26]  J. Alger,et al.  High‐field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy , 1989, Neurology.

[27]  R G Shulman,et al.  Spatially localized 1H NMR spectra of metabolites in the human brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Spencer,et al.  Surgery for epilepsy. , 1985, Neurologic clinics.

[29]  M. Erecińska,et al.  Relationships Among ATP Synthesis, K+ Gradients, and Neurotransmitter Amino Acid Levels in Isolated Rat Brain Synaptosomes , 1987, Journal of neurochemistry.

[30]  K. Behar,et al.  Assignment of resonances in the 1H spectrum of rat brain by two‐dimensional shift correlated and j‐resolved NMR spectroscopy , 1991, Magnetic resonance in medicine.

[31]  M Noble,et al.  Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.

[32]  K. Rimvall,et al.  The Level of GAD67 Protein Is Highly Sensitive to Small Increases in Intraneuronal γ‐Aminobutyric Acid Levels , 1994, Journal of neurochemistry.

[33]  François Lazeyras,et al.  Magnetic Resonance in Preterm and Term Newborns: 1H-Spectroscopy in Developing Human Brain , 1991, Pediatric Research.

[34]  G. Matson,et al.  Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging , 1993, Annals of neurology.

[35]  Jullie W Pan,et al.  Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T , 1994, Magnetic resonance in medicine.

[36]  M. During,et al.  Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain , 1993, The Lancet.

[37]  J. Coyle,et al.  N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.

[38]  E. Novotny,et al.  In Vivo Measurements of Ethanol Concentration in Rabbit Brain by 1H Magnetic Resonance Spectroscopy , 1990, Journal of neurochemistry.

[39]  T. Halonen,et al.  Amino Acid Levels in the Cerebrospinal Fluid of Newly Diagnosed Epileptic Patients: Effect of Vigabatrin and Carbamazepine Monotherapies , 1993, Journal of neurochemistry.

[40]  Brain Energy State and Lactate Metabolism during Status Epilepticus in the Neonatal Dog: In Vivo 31P and 1H Nuclear Magnetic Resonance Study , 1991, Pediatric Research.

[41]  R. Mattson,et al.  Initial Observations on Effect of Vigabatrin on In Vivo 1H Spectroscopic Measurements of γ‐Aminobutyric Acid, Glutamate, and Glutamine in Human Brain , 1995, Epilepsia.

[42]  S. Sonoda,et al.  Extent of pyramidal tract wallerian degeneration in the brain stem on MRI and degree of motor impairment after supratentorial stroke. , 1992, Disability and rehabilitation.

[43]  R G Shulman,et al.  High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Rolf Gruetter,et al.  Localized 13C NMR Spectroscopy in the Human Brain of Amino Acid Labeling from d‐[1‐13C]Glucose , 1994, Journal of neurochemistry.

[45]  J. Cooper,et al.  N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.

[46]  J. Peeling,et al.  1H Magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus , 1993, Neurology.

[47]  S. Gullans,et al.  Characterization of the major brain osmolytes that accumulate in salt-loaded rats. , 1989, The American journal of physiology.

[48]  A. Blamire,et al.  Proton spectroscopy of human stroke: assessment of transverse relaxation times and partial volume effects in single volume steam MRS. , 1994, Magnetic resonance imaging.

[49]  P. Matthews,et al.  A proton magnetic resonance spectroscopy study of focal epilepsy in humans , 1990, Neurology.

[50]  D. Gadian,et al.  Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.

[51]  van Gelder Nm,et al.  Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy. , 1986 .

[52]  O. Petroff,et al.  Effects of glutamate, quisqualate, and N-methyl-d-aspartate in neonatal brain , 1991, Experimental Neurology.

[53]  A. Brancati,et al.  Distribution of N-acetylaspartate, N-acetylaspartylglutamate, free glutamate and aspartate following complete mesencephalic transection in rat neuraxis , 1990, Neuroscience Letters.

[54]  T. Ebisu,et al.  N-Acetylaspartate as an in vivo Marker of Neuronal Viability in Kainate-Induced Status Epilepticus: 1H Magnetic Resonance Spectroscopic Imaging , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  Jeff H. Duyn,et al.  Transsynaptic Reduction in N‐Acetyl‐Aspartate in Cerebellar Diaschisis: A Proton MR Spectroscopic Imaging Study , 1994, Journal of computer assisted tomography.

[56]  R. Post,et al.  Low cerebrospinal fluid γ‐aminobutyric acid content in seizure patients , 1979, Neurology.

[57]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[58]  M. Décorps,et al.  In Vivo, Ex Vivo, and In Vitro One‐ and Two‐Dimensional Nuclear Magnetic Resonance Spectroscopy of an Intracerebral Glioma in Rat Brain: Assignment of Resonances , 1994, Journal of neurochemistry.

[59]  J. Gotman,et al.  Excitatory amino acids are elevated in human epileptic cerebral cortex , 1988, Neurology.

[60]  R. Shulman,et al.  Localized 1H NMR spectra of glutamate in the human brain , 1992, Magnetic resonance in medicine.

[61]  R. Kaul,et al.  Purification, Characterization, and Localization of Aspartoacylase from Bovine Brain , 1991, Journal of neurochemistry.

[62]  M. Palkovits,et al.  Effect of optic nerve transection onN-acetylaspartylglutamate immunoreactivity in the primary and accessory optic projection systems in the rat , 1991, Brain Research.

[63]  G. Fein,et al.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.

[64]  A. Briguet,et al.  Perspectives d'emploi de la RMN pour l'étude biochimique de la substance blanche cérébrale , 1985 .

[65]  T. Perry,et al.  Postmortem Changes of Amino Compounds in Human and Rat Brain , 1981, Journal of neurochemistry.

[66]  R. Swanson,et al.  Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. , 1992, Canadian journal of physiology and pharmacology.

[67]  R. Mattson,et al.  Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Bizzi,et al.  Absolute Quantitation of Short TE Brain 1H‐MR Spectra and Spectroscopic Imaging Data , 1993, Journal of computer assisted tomography.

[69]  R. Shulman,et al.  Effect of Hypoglycemic Encephalopathy upon Amino Acids, High‐Energy Phosphates, and pHi in the Rat Brain In Vivo: Detection by Sequential 1H and 31P NMR Spectroscopy , 1985, Journal of neurochemistry.

[70]  T. Perry Cerebral Amino Acid Pools , 1982 .

[71]  J. Neale,et al.  Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.

[72]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[73]  P. Morselli,et al.  Alterations of GABA-mediated synaptic transmission in human epilepsy. , 1984, Advances in neurology.

[74]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[75]  T. Perry,et al.  REGIONAL DISTRIBUTION OF AMINO ACIDS IN HUMAN BRAIN OBTAINED AT AUTOPSY , 1971, Journal of neurochemistry.

[76]  K R Maravilla,et al.  The fornix in patients with seizures caused by unilateral hippocampal sclerosis: detection of unilateral volume loss on MR images. , 1994, AJR. American journal of roentgenology.

[77]  R. Kuzniecky,et al.  In vivo 31P nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy , 1992, Neurology.

[78]  S. Spencer Surgical options for uncontrolled epilepsy. , 1986, Neurologic clinics.

[79]  A. Blamire,et al.  Spectroscopic imaging of stroke in humans , 1992, Neurology.

[80]  Takashi Ogino,et al.  Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain , 1993, Magnetic resonance in medicine.

[81]  T. Patel,et al.  Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. , 1979, The Biochemical journal.

[82]  R. Mattson,et al.  Vigabatrin: Effects on Human Brain GABA Levels by Nuclear Magnetic Resonance Spectroscopy , 1994, Epilepsia.

[83]  Graeme D. Jackson,et al.  Magnetic Resonance in Epilepsy , 1994 .

[84]  E. Novotny,et al.  In vivo 31P and in vitro 1H nuclear magnetic resonance study of hypoglycemia during neonatal seizure , 1987, Annals of neurology.

[85]  T. Bohan,et al.  Regional in vivo proton magnetic resonance spectroscopy of brain , 1989 .

[86]  A. Hamberger,et al.  Amino acids in the neuronal microenvironment of focal human epileptic lesions , 1991, Epilepsy Research.

[87]  R. Gruetter,et al.  Localized 13C NMR spectroscopy of myo‐inositol in the human brain in vivo , 1992, Magnetic resonance in medicine.

[88]  B. Ross,et al.  Brief report: organic osmolytes in the brain of an infant with hypernatremia. , 1994, The New England journal of medicine.

[89]  K. Fukui,et al.  Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome After Supratentorial Hemorrhagic Stroke , 1994, Stroke.

[90]  D J Mikulis,et al.  Wallerian degeneration after cerebral infarction: evaluation with sequential MR imaging. , 1989, Radiology.

[91]  A. Blamire,et al.  Early Temporal Variation of Cerebral Metabolites After Human Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1993, Stroke.

[92]  T. Tsumita,et al.  Gaschromatographic analysis of free myo- and scyllo-inositols in animal tissues. , 1969, The Japanese journal of experimental medicine.

[93]  P. Manos,et al.  Creatine Kinase Activity in Postnatal Rat Brain Development and in Cultured Neurons, Astrocytes, and Oligodendrocytes , 1991, Journal of neurochemistry.

[94]  P. Goldman-Rakic,et al.  Proton magnetic resonance spectroscopy in Creutzfeldt‐Jakob disease , 1993, Neurology.

[95]  D. Gadian,et al.  Advances in proton magnetic resonance spectroscopy of the brain , 1993 .

[96]  O. Petroff,et al.  High‐Resolution Proton Magnetic Resonance Analysis of Human Cerebrospinal Fluid , 1986, Journal of neurochemistry.

[97]  A. Blamire,et al.  Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. , 1995, Stroke.